Toxicity with radiotherapy for oral cancers and its management: A practical approach

Journal of Cancer Research and Therapeutics

Volumn 8, Issue SUPPL. 2, 2012, Pages

  Basu, Trinanjan ^a   Laskar, Sarbani G ^a   Gupta, Tejpal ^a   Budrukkar, Ashwini ^a   Murthy, Vedang ^a   Agarwal, Jai P ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

Future directions; management; pathobiology; QOL; radiation toxicity

Indexed keywords

2 (3 AMINOPROPYLAMINO)ETHANETHIOL; AMIFOSTINE; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; AZELASTINE; BENZYDAMINE; BETA CAROTENE; CEVIMELINE; CHLORHEXIDINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DEXPANTHENOL; EMOLLIENT AGENT; GLUTAMIC ACID; HYALURONIC ACID; INDOMETACIN; LUBRICATING AGENT; METHYLPREDNISOLONE ACEPONATE; MUSCLE RELAXANT AGENT; PALIFERMIN; PENTOXIFYLLINE; PILOCARPINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; SUCRALFATE; TRICYCLIC AROMATIC COMPOUND;

AMNION; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; BASEMENT MEMBRANE; BONE NECROSIS; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CELL DEATH; CELL MIGRATION; CELL PROTECTION; DISEASE SEVERITY; EPITHELIUM CELL; GENE EXPRESSION; HEAD AND NECK CANCER; HUMAN; HYPERBARIC OXYGEN; HYPERPIGMENTATION; INCIDENCE; LOW DRUG DOSE; MORBIDITY; MOUTH CANCER; MUCOSA INFLAMMATION; NONHUMAN; NUTRITIONAL STATUS; OINTMENT; PATHOGENESIS; PHASE 2 CLINICAL TRIAL (TOPIC); PIGMENTATION; RADIATION DOSE; REVIEW; SALIVATION; SKIN EXFOLIATION; SKIN TOXICITY; TOOTH DISEASE; TOXICITY; TRISMUS; ULCER; XEROSTOMIA;

HUMANS; MOUTH MUCOSA; MOUTH NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY;

EID: 84856884641     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/0973-1482.92219     Document Type: Review

References (164)

1. MCQuestion M. Evidence-Based Skin-Care Management in Radiation Therapy. Semin Oncol Nurs 2006;22:163-73. (Pubitemid 44163101)
2. Ratliff C. Impaired skin integrity related to radiation therapy. J Enterostom Ther 1990;17:193-8.
3. Denham JW, Hauer-Jensen M. The radiotherapeutic injury - A complex 'wound'. Radiother Oncol 2002;63:129-45.
4. Ali SY, Singh G. Radiation-induced Alopecia. Int J Trichol 2010;2: 118-9.
5. Malkinson FD, Panizzon RG. Radiobiology and radiotherapy of skin diseases. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, et al. Editors, Fitzpatricks dermatology in general medicine. 6th ed. 2003. p. 1229-38.
6. Noble-Adams R. Radiation-induced reactions. An examination of the phenomenon. Br J Nurs 1999;8:1134-40.
7. Bolderston A, Lloyd NS, Wong RK, Holden L, Robb-Blenderman. The prevention and management of acute skin reactions related to radiation therapy: A systematic review and practice guideline. Support Care Cancer 2006;14:802-17. (Pubitemid 44060993)
8. Korinko A, Yurick A. Maintaining skin integrity during radiotherapy. Am J Nurs 1997;97:40-4.
9. Barkham AM. Radiotherapy skin reactions and treatments. Prof Nurse 1993;8:732-6.
10. Bolderston A. Skin care recommendations during radiotherapy: A survey of Canadian practice. Can J Med Radiat Technol 2002;34:3-11.
11. Campbell J, Lane C. Developing a skin-care protocol in radiotherapy. Prof Nurse 1996;12:105-8.
12. Porock D. Factors influencing the severity of radiation skin and oral mucosal reactions: Development of a conceptual framework. Eur J Cancer Care 2002;11:33-43.
13. Sitton E. Early and late radiation-induced skin alterations. Part II: Nursing care of irradiated skin. Oncol Nurs Forum 1992;19:907-12.
14. Frosch P, Kligman A. The soap chamber: A new method for assessing the irritancy of soaps. J Am Acad Dermatol 1979;1:35-41. (Pubitemid 11160085)
15. Fenig E, Brenner B, Katz A, Sulkes J, Lapidot M, Schachter J, et al. Topical biafine and lipiderm for the prevention of radiation dermatitis: A randomized prospective trial. Oncol Rep 2001;8:305-9. (Pubitemid 33758083)
16. Maiche AG, Grohn P, Maki-Hokkonen H. Effect of chamomile cream and almond ointment on acute radiation skin reaction. Acta Oncol 2001;30:395-6.
17. Bostrom A, Lindman H, Swartling C, Berne B, Bergh J. Potent corticosteroid cream (mometasone furoate) significantly reduces acute radiation dermatitis: Results from a double-blind, randomized study. Radiother Oncol 2001;59:257-65. (Pubitemid 32429573)
18. Schmuth M, Wimmer MA, Hofer S, Sztankay A, Weinlich G, Linder DM, et al. Topical corticosteroid therapy for acute radiation dermatitis: A prospective, randomized, double-blind study. Br J Dermatol 2002;146:983-91. (Pubitemid 34779478)
19. Schreck U, Paulsen F, Bamberg M, Budach W. Intraindividual comparison of two different skin care conceptions in patients undergoing radiotherapy of the head-and-neck region. Strahlenther Onkol 2002;6:321-9. (Pubitemid 34632645)
20. Potera ME, Lookingbill DP, Stryker JA. Prophylaxis of radiation dermatitis with a topical cortisone cream. Radiother Oncol 1982;143:775-7. (Pubitemid 12129333)
21. Liguori V, Guillemin C, Pesce GF, Mirimanoff RO, Bernier J. Doubleblind randomized clinical trial comparing hyaluronic acid cream to placebo in patients treated with radiotherapy. Radiother Oncol 1997;42:155-61. (Pubitemid 27132744)
22. Evensen JF, Bjordal K, Jacobsen AB, Løkkevik E, Tausjø JE. Effects of Na-sucrose octasulfate on skin and mucosa reactions during radiotherapy of head and neck cancers. Acta Oncol 2001;40:751-5. (Pubitemid 33081985)
23. Lievens Y, Haustermans K, Van den Weyngaert D, Van den Bogaert W, Scalliet P, Hutsebaut L, et al. Does sucralfate reduce the acute side-effects in head and neck cancer treated with radiotherapy? A double-blind randomized trial. Radiother Oncol 2001;47:149-53. (Pubitemid 28275924)
24. Delaney G, Fisher R, Hook C, Barton M. Sulcrafate cream in the management of moist desquamation during radiotherapy. Australas Radiol 1997;41:270-5. (Pubitemid 27360215)
25. Shell JA, Stanutz F, Grimm J. Comparison of moisture vapor permeable (MVP) dressings to conventional dressings for the management of radiation skin reactions. Oncol Nurs Forum 1986;13:11-6.
26. Vilela-Goulart MG, Teixeira RT, Rangel DC, Niccoli-Filho W, Gomes MF, et al. Homogenous amniotic membrane as a biological dressing for oral mucositis in rats: Histomorphometric analysis. Arch Oral Biol 2008;53:1163-71.
27. Gruss JS, Jirsch DW. Human amniotic membrane: A versatile wound dressing. Can Med Assoc J 1978;118:1237-46. (Pubitemid 8350868)
28. Mohammadi AA, Sabet B, Riazi H, Tavakkolian AR, Mohammadi MK. Human Amniotic Membrane Dressing: An Excellent Method for Outpatient Management of Burn Wounds. Indian J Med Sci 2009;34:1.
29. Lobo Gajiwala A, Sharma V. Use of irradiated amnion as a biological dressing in the treatment of radiation induced ulcers. Cell Tissue Bank 2003;4:147-50. (Pubitemid 38094232)
30. Judith E. Raber-Durlacher. Current practices for management of oral mucositis in cancer patients. Support Care Cancer 1999;7:71-4. (Pubitemid 29140738)
31. Sonis ST. Mucositis: The impact, biology and therapeutic opportunities of oral mucositis. Oral Oncol 2009;45:1015-20.
32. Keefe DM. Mucositis guidelines: What have they achieved, and where to from here? Support Care Cancer 2006;14:489-91.
33. Cheng KK, Leung SF, Thompson DR, Tai JW, Liang RH, Kan AS, et al. New Measure of Health-Related Quality of Life for Patients With Oropharyngeal Mucositis: Development and Preliminary Psychometric Evaluation. Cancer 2007;109:2590-9. (Pubitemid 46906480)
34. Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, Gwede CK, et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: A systematic literature review. Radiother Oncol 2003;66:253-62. (Pubitemid 36556043)
35. Worthington HV, Clarkson JE, Bryan G, Furness S, Glenny AM, Littlewood A, et al. Interventions for preventing oral mucositis for patients with cancer receiving treatment (Review). Cochrane Database Syst Rev 2011;4:CD000978.
36. Ps SK, Balan A, Sankar A, Bose T Radiation Induced Oral Mucositis. Indian J Palliat Care 2009;15:95-102.
37. Vissink A, Jansma J, Spijkervet FK, Burlage FR, Coppes RP. Oral sequelae of head and neck radiotherapy. Crit Rev Oral Biol Med 2003;14:199-212. (Pubitemid 44560804)
38. Vissink A, Burlage FR, Spijkervet FK, Jansma J, Coppes RP. Prevention and Treatment of the Consequences of Head and Neck Radiotherapy. Crit Rev Oral Biol Med 2003;14:213-25. (Pubitemid 44560805)
39. Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M et al. Perspectives on Cancer Therapy-Induced Mucosal Injury Pathogenesis, Measurement, Epidemiology, and Consequences for Patients. Cancer 2004;100:1995-2025. (Pubitemid 38528741)
40. Sciubba JJ, Goldenberg D Oral complications of radiotherapy. Lancet Oncol 2006;7:175-83. (Pubitemid 43159504)
41. Lalla RV, Sonis ST, Peterson DE. Management of Oral Mucositis in Patients with Cancer. Dent Clin North Amr 2008;52:61-8.
42. Stokman MA, Spijkervet FK, Burlage FR, Dijkstra PU, Manson WL, de Vries EG, et al. Oral mucositis and selective elimination of oral flora in head and neck cancer patients receiving radiotherapy: A double-blind randomised clinical trial. Br J Cancer 2003;88:1012-6. (Pubitemid 36560767)
43. Eilers J, Million R. Prevention and management of Oral Mucositis in patients with cancer. Semin Oncol Nurs 2007;23:201-12.
44. Scully C, Epstein J, Sonis S. Oral mucositis: A challenging complication of radiotherapy, chemotherapy and radio-chemotherapy part 2: Diagnosis and management of mucositis. Head Neck 2004;26:77-84. (Pubitemid 38030154)
45. Arvitscher EBC, Cooksley CD, Elting LS. Scope and epidemiology of cancer therapy-induced oral and gastrointestinal mucositis. Semin Oncol Nurs 2004;20:3-10. (Pubitemid 38609552)
46. Eilers J, Berger AM, Petersen MC. Development, testing and application of the oral assessment guide. Oncol Nurs Forum 1988;15:325-30.
47. Sonis ST, Eilers, JG, Epstein JB, LeVeque FG, Liggett WH Jr, Mulagha MT, et al. Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Mucositis Study Group. Cancer 1999;85:2103-13. (Pubitemid 29215547)
48. Jaroneski LA. The importance of assessment rating scales for chemotherapy-induced oral mucositis. Oncol Nurs Forum 2006;33:1085-93.
49. Rubenstein EB, Peterson DE, Schubert M, Keefe D, McGuire D, Epstein J, et al. Clinical Practice Guidelines for the Prevention and Treatment of Cancer Therapy-Induced Oral and Gastrointestinal Mucositis. Cancer 2004;100:2026-46. (Pubitemid 38525884)
50. Bonnaure-Mallet M, Bunetel L, Tricot-Doleux S, Guerin J, Bergeron C, LeGall E. Oral complications during treatment of malignant diseases in childhood: effects of tooth brushing. Eur J Cancer 1998;34: 1588-91. (Pubitemid 28446342)
51. Christman N, Kirchhoff K, Oakley M. Concrete objective information. In: Bulecheck G, McCloskey J, editors. Nursing interventions: Essential nursing treatments. 2nd ed. Philadelphia: WB Saunders; 1992. p. 140-80.
52. Graham K, Pecoraro D, Ventura M, Meyer C. Reducing the incidence of stomatitis using a quality assessment and improvement approach. Cancer Nurs 1993;16:117-22. (Pubitemid 23119161)
53. Dudjak L. Mouth care for mucositis due to radiation therapy. Cancer Nurs 1987;10:131-40.
54. Rosenbaum EH, Rosenbaum IR. Helpful Hints for managing mouth ulcers. Supportive Cancer Care. This page was last edited on 7/23/2008.
55. Foote RL, Loprinzi CL, Frank AR, O'Fallon JR, Gulavita S, Tewfik HH, et al. Randomized trial of a chlorhexidine mouthwash for alleviation of radiation-induced mucositis. J Clin Oncol 1994;12:2630-3. (Pubitemid 24379649)
56. Samaranayake LP, Robertson AG, MacFarlane TW, Hunter IP, MacFarlane G, Soutar DS, et al. The effect of chlorhexidine and benzydamine mouthwashes on mucositis induced by therapeutic irradiation. Clin Radiol 1988;39:291-4.
57. Spijkervet FK, van Saene HK, Panders AK, Vermey A, van Saene JJ, Mehta DM, et al. Effect of chlorhexidine rinsing on the oropharyngeal ecology in patients with head and neck cancer who have irradiation mucositis. Oral Surg Oral Med Oral Pathol 1989;67:154-61. (Pubitemid 19056746)
58. Dennis L Carter, Mary E Herbert, Karen Smink, David M Brizel. Double blind randomized trial of sucralfate vs placebo during radical radiotherapy for head and neck cancer. Head Neck 1999;8760-6.
59. Dodd MJ, Miaskowski C, Greenspan D, MacPhail L, Shih AS, Shiba G, et al. Radiation-induced mucositis: A randomized clinical trial of micronized sucralfate versus salt and soda mouthwashes. Cancer Invest 2003;21:21-33. (Pubitemid 36292504)
60. Raber-Durlacher JE, Elad S, Barasch A. Oral mucositis. Oral Oncol 2010;46:452-6.
61. Kim JH, Chu FC, Lakshmi V, Houde R. Benzydamine HCl, a new agent for the treatment of radiation mucositis of the oropharynx. Am J Clin Oncol 1986;9:132-4. (Pubitemid 16115725)
62. Epstein JB. Oral and pharyngeal candidiasis. Topical agents for management and prevention. Postgrad Med 1989;85:257-69. (Pubitemid 19112099)
63. Epstein JB, Silverman S Jr, Paggiarino DA, Crockett S, Schubert MM, Senzer NN, et al. Benzydamine HCl for prophylaxis of radiation-induced oral mucositis: Results from a multicenter, randomized, double-blind, placebo-controlled clinical trial. Cancer 2001;92: 875-85. (Pubitemid 32783076)
64. Bensadoun RJ, Schubert MM, Lalla RV, Keefe. Amifostine in the management of radiation-induced and chemo-induced mucositis. Support Care Cancer 2006;14:566-72.
65. Barasch A, Elad S, Altman A, Damato K, Epstein J. Antimicrobials, mucosal coating agents,anesthetics, analgesics, and nutritional supplements for alimentary tract mucositis. Support Care Cancer 2006;14:528-32.
66. El-Sayed S, Nabid A, Shelley W, Hay J, Balogh J, Gelinas M, et al. Prophylaxis of radiation-associated mucositis in conventionally treated patients with head and neck cancer: A double-blind, phase III randomized controlled trial evaluating the clinical efficacy of an antimicrobial lozenge using a validated mucositis scoring system. J Clin Oncol 2002;20:3956-63.
67. Perch SJ, Machtay M, Markiewicz DA, Kligerman MM. Decreased acute toxicity by using midline mucosa-sparing blocks during radiation therapy for carcinoma of the oral cavity, oropharynx, and nasopharynx. Radiology 1995;197:863-6.
68. Ship JA, Eisbruch A, D'Hondt E, Jones RE. Parotid sparing study in head and neck cancer patients receiving bilateral radiation therapy: One-year results. J Dent Res 1997;76:807-13. (Pubitemid 127732671)
69. Blijlevens N, Sonis S. Palifermin (recombinant keratinocyte growth factor-1): A pleiotropic growth factor with multiple biological activities in preventing chemotherapy- and radiotherapy-induced mucositis. Ann Oncol 2007;18:817-26. (Pubitemid 47054077)
70. Rubin JS, Bottaro DP, Chedid M, Miki T, Ron D, Cheon G, et al. Keratinocyte growth factor. Cell Biol Int 1995;19:399-411.
71. Farrell CL, Rex KL, Chen JN, Bready JV, DiPalma CR, Kaufman SA, et al. The effects of keratinocyte growth factor in preclinical models of mucositis. Cell Prolif 2002;35:78-85. (Pubitemid 34985150)
72. Brizel DM, Murphy BA, Rosenthal DI, Pandya KJ, Glück S, Brizel HE, et al. Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma. J Clin Oncol 2008;20: 2489-96.
73. Henke M, Alfonsi M, Foa P, Giralt J, Bardet E, Cerezo L, et al. Palifermin Decreases Severe Oral Mucositis of Patients Undergoing Postoperative Radiochemotherapy for Head and Neck Cancer: A Randomized, Placebo-Controlled Trial. J Clin Oncol 2011;29:2815-20.
74. Henke M, Alfonsi M, Foa P, Giralt J, et al. A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Advanced Head and Neck Cancer. JCO 2011 [In press].
75. Kannan V, Bapsy PP, Anantha N, Doval DC, Vaithianathan H, Banumathy G, et al. Efficacy and safety of granulocyte macrophagecolony stimulating factor (GM-CSF) on the frequency and severity of radiation mucositis in patients with head and neck carcinoma. Int J Radiat Oncol Biol Phys 1997;37:1005-10. (Pubitemid 27230023)
76. Posten W, Wrone DA, Dover JS, Arndt KA, Silapunt S, Alam M. Low-Level Laser Therapy for Wound Healing: Mechanism and Efficacy. Dermatol Surg 2005;31:334-40. (Pubitemid 43072992)
77. Genot MT, Klastersky J. Low-level laser for prevention and therapy of oral mucositis induced by chemotherapy or radiotherapy. Curr Opin Oncol 2005;17:236-40. (Pubitemid 40586163)
78. Dirix P, Nuyts S, Van den Bogaert W. Radiation-Induced Xerostomia in Patients With Head and Neck Cancer: A Literature Review. Cancer 2006;107:2525-34. (Pubitemid 44845604)
79. Wijers OB, Levendag PC, Braaksma MM, Boonzaaijer M, Visch LL, Schmitz PI, et al. Patients with head and neck cancer cured by radiation therapy: A survey of the dry mouth syndrome in long term survivors. Head Neck 2002;24:737-47. (Pubitemid 34857299)
80. Sandow PL, Hejrat-Yazdi M, Heft MW. Taste Loss and Recovery Following Radiation Therapy. J Dent Res 2006;85:608-11. (Pubitemid 44085949)
81. Porter SR, Scully C, Hegarty AM. An update of the etiology and management of xerostomia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;97:28-46. (Pubitemid 38067257)
82. Jenkins G. The physiology of the mouth. In: Jenkins G, editor. The physiology of the mouth. 3rd ed. Oxford: Blackwell Scientific Publications; 1966. p. 328.
83. Rauch S. Die speicheldrusen des menschen. In: Rauch S, editor. Anatomie, physiologie, und klinische pathologie. Stuttgart: Thieme; 1959.
84. Nagler RM. The enigmatic mechanism of irradiation-induced damage to the major salivary glands. Oral Dis 2002;8:141-6. (Pubitemid 34535062)
85. Konings AW, Coppes RP, Vissink. On The Mechanism of Salivary Gland Radiosensitivity. Int. J. Radiat Oncol Biol Phys 2005;62:1187-94. (Pubitemid 40884434)
86. Abok K, Brunk U, Jung B, Ericsson J. Morphologic and histochemical studies of the deferring radiosensitivity of the ductular and acinar cell of the rat submandibular gland. Virchows Arch Cell Pathol 1984;45:443-60. (Pubitemid 14139640)
87. Nelson GM. Biology of taste buds and the clinical problem of taste loss. Anat Rec 1998;253:70-8. (Pubitemid 28387744)
88. Eisbruch A, Kim HM, Terrell JE, Marsh LH, Dawson LA, Ship JA. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001;50:695-704. (Pubitemid 32515326)
89. Roesink JM, Konings AW, Terhaard CH, Battermann JJ, Kampinga HH, Coppes RP. Preservation of the rat parotid gland function after radiation by prophylactic pilocarpine treatment: Radiation dose dependency and compensatory mechanisms. Int J Radiat Oncol Biol Phys 1999;45:483-9. (Pubitemid 29408568)
90. Chambers MS, Garden AS, Kies MS, Martin JW. Radiation induced xerostomia in patients with head and neck cancer: Pathogenesis, impact on quality of life, and management. Head Neck 2004;26: 796-807. (Pubitemid 39159303)
91. Epstein JB, Emerton S, Kolbinson DA, Le ND, Phillips N, Stevenson-Moore P, et al. Quality of Life and Oral Function Following Radiotherapy for Head and Neck Cancer. Head Neck 1999;21:1-11. (Pubitemid 29006450)
92. Hamlet S, Faull J, Klein B, Aref A, Fontanesi J, Stachler R, et al. Mastication and Swallowing in Patients With Postirradiation Xerostomia. Int J Radiation Oncology Biol Phys 1997;37:789-96. (Pubitemid 27181310)
93. Roh JL, Kim AY, Cho MJ. Xerostomia Following Radiotherapy of the Head and Neck Affects Vocal Function. J Clin Oncol 2005;23:3016-23. (Pubitemid 46224122)
94. Zheng WK, Inokuchi A, Yamamoto T, Komiyama S. Taste dysfunction in irradiated patients with head and neck cancer. Fukuoka Igaku Zasshi 2002;93:64-76.
95. Konings AW, Coppes RP, Vissink A. On the mechanism of salivary gland radiosensitivity. Int J Radiat Oncol Biol Phys 2005;62:1187-94. (Pubitemid 40884434)
96. Bensadoun RJ, Schubert MM, Lalla RV, Keefe D. Amifostine in the management of radiation-induced and chemo-induced mucositis. Support Care Cancer 2006;14:566-72.
97. Buntzel J, Glatzel M, Kuttner K, Weinaug R, Frohlich D. Amifostine in simultaneous radiochemotherapy of advanced head and neck cancer. Semin Radiat Oncol 2002;12:4-13. (Pubitemid 34246062)
98. Schuchter LM, Hensley ML, Meropol NJ, Winer EP. Update of recommendations for the use of chemotherapy and radiotherapy protectants: Clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2002;20:2895-903. (Pubitemid 34651519)
99. Lin A, Kim HM, Terrell JE, Dawson LA, Ship JA, Eisbruch A. Quality of life after parotid sparing IMRT for head-and-neck cancer: A prospective longitudinal study. Int J Radiat Oncol Biol Phys 2003;57:61-70. (Pubitemid 36959739)
100. Henson BS, Inglehart MR, Eisbruch A, Ship JA. Preserved salivary output and xerostomia-related quality of life in head and neck cancer patients receiving parotid-sparing radiotherapy. Oral Oncol 2001;37:84-93.
101. Malouf JG, Aragon C, Henson BS, Eisbruch A, Ship JA. Influence of parotid sparing radiotherapy on xerostomia in head and neck cancer patients. Cancer Detect Prev 2003;27:305-10. (Pubitemid 36990250)
102. Momm F, Volegova-Neher N, Schulte-Monting J, Guttenberger R. Different saliva substitutes for treatment of xerostomia following radiotherapy: A prospective crossover study. Strahlenther Onkol 2005;181:231-6. (Pubitemid 40585542)
103. Vissink A, Burlage FR, Spijkervet FK, Jansma J, Coppes RP. Prevention and treatment of the consequences of head and neck radiotherapy. Crit Rev Oral Biol Med 2003;14:213-25. (Pubitemid 44560805)
104. Vissink A, Johannes's-Gravenmade E, Panders AK, Vermey A. Treatment of hyposalivation. Ear Nose Throat J 1988;67:179-85.
105. Johnson JT, Ferretti GA, Nethery WJ, Valdez IH, Fox PC, Ng D, et al. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. N Engl J Med 1993;329:390-5. (Pubitemid 23219343)
106. Warde P, O'Sullivan B, Aslanidis J, Kroll B, Lockwood G, Waldron J, et al. A phase III placebo controlled trial of oral pilocarpine in patients undergoing radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2002;54:9-13.
107. Ship JA, Hu K. Radiotherapy-induced salivary dysfunction. Semin Oncol 2004;31:29-36. (Pubitemid 40250141)
108. Niedermeier W, Matthaeus C, Meyer C, Staar S, Müller RP, Schulze HJ. Radiation-induced hyposalivation and its treatment with oral pilocarpine. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;86:541-9. (Pubitemid 128644744)
109. Seikaly H, Jha N, McGaw T, Coulter L, Liu R, Oldring D. Submandibular Gland Transfer: A New Method of Preventing Radiation-Induced Xerostomia. Laryngoscope 2001;111:347-52. (Pubitemid 32143759)
110. Jha N, Seikaly H, McGaw T, Coulter L. Submandibular Salivary Gland Transfer Prevents Radiation -Induced Xerostomia. Int J Radiat Oncol Biol Phys 2000;46:7-11. (Pubitemid 30021472)
111. Baum BJ, Zheng C, Cotrim AP, McCullagh L, Goldsmith CM, Brahim JS, et al. Aquaporin-1 Gene Transfer to Correct Radiation-Induced Salivary Hypofunction. Handb Exp Pharmacol 2009;190:403-18.
112. Vitolo JM, Baum BJ. The use of gene transfer for the protection and repair of salivary glands. Oral Dis 2002;8:183-91. (Pubitemid 34815223)
113. Hamlet S, Faull J, Klein B, Aref A, Fontanesi J, Stachler R, et al. Mastication and Swallowing in Patients With Postirradiation Xerostomia. Int J Radiat Oncol Biol Phys 1997;37:789-96. (Pubitemid 27181310)
114. Agarwal J, Palwe V, Dutta D, Gupta T, Laskar SG, Budrukkar A, et al. Objective Assessment of Swallowing Function After Definitive Concurrent (Chemo) radiotherapy in Patients with Head and Neck Cancer. Dysphagia 2011 [EIn Press].
115. Vissink A, Jansma J, Spijkervet FK, Burlage FR, Coppes RP. Oral Sequelae of Head and Neck Radiotherapy. Crit Rev Oral Biol Med 2003;14:199-212. (Pubitemid 44560804)
116. Ogama N, Suzuki S, Umeshita K, Kobayashi T, Kaneko S, Kato S, et al. Appetite and adverse effects associated with radiation therapy in patients with head and neck cancer. Eur J Oncol Nurs 2010;14:3-10.
117. Peponi E, Glanzmann C, Willi B, Huber G, Studer G. Dysphagia in head and neck cancer patients following intensity modulated radiotherapy (IMRT). Radiat Oncol 2011;6:1.
118. Jansma J, Vissink A, Spijkervet FK, Roodenburg JL, Panders AK, Vermey A, et al. Protocol for the Prevention and Treatment of Oral Sequelae Resulting from Head and Neck Radiation Therapy. Cancer 1992;70:2171-80.
119. Sandow PL, Hejrat-Yazdi M, Heft MW. Taste Loss and Recovery Following Radiation Therapy. J Dent Res 2006;85:608.
120. Bruins HH, Jolly DE, Koole R. Preradiation Dental Decisions in Patients With Head and Neck Cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;88:406-12.
121. Hulya Cankaya H, Pelin Guneri P. Importance of a Dental Approach in Head and Neck Cancer Therapy. APJOH 2010;2:(1).
122. Soares CJ, Castro CG, Neiva NA, Soares PV, Santos-Filho PC, Naves LZ, et al. Effect of Gamma Irradiation on Ultimate Tensile Strength of Enamel and Dentin. J Dent Res 2010;89:159-64.
123. Miguez PA, Pereira PN, Atsawasuwan P, Yamauchi M. Collagen cross linking and ultimate tensile strength in dentin. J Dent Res 2004;83:807-10. (Pubitemid 41766164)
124. Lertchirakarn V, Palamara JE, Messer HH. Anisotropy of tensile strength of root dentin. J Dent Res 2001;80:453-6. (Pubitemid 32378951)
125. Rothwell BR. Prevention and treatment of the orofacial complications of radiotherapy. J Am Dent Assoc 1987;114:316-22.
126. Kielbassa AM, Hinkelbein W, Hellwig E, Meyer-Luckel H. Radiation related damage to dentition. Lancet Oncol 2006;7:326-35.
127. Epstein JB, Lunn R, Le N, Stevenson-Moore P. Periodontal attachment loss in patients after head and neck radiation therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;86:673-7. (Pubitemid 128642477)
128. Marques MA, Dib LL. Periodontal changes in patients undergoing radiotherapy. J Periodontol 2004;75:1178-87. (Pubitemid 39419715)
129. Stevenson-Moore P, Epstein JB. The management of teeth in irradiated sites. Oral Onc J Eur Cancer 1993;29B:39-43. (Pubitemid 23068395)
130. National Cancer Institute Report no. 208/10577. Oral complications of chemotherapy and head/neck radiation.
131. Parulekar W, Mackenzie R, Bjarnason G, Jordan RC. Scoring oral mucositis. Oral Oncol 1998;34:63-71. (Pubitemid 28210533)
132. Schiodt M, Hermund NU. Management of oral disease prior to radiation therapy. Support Care Cancer 2002;10:40-3. (Pubitemid 36055883)
133. Huber MA, Terezhalmy GT. The head and neck radiation oncology patient. Quintessence Int 2003;34:693-17.
134. Dijkstraa PU, Kalka WW, Roodenburg JL. Trismus in head and neck oncology: A systematic review. Oral Oncology 2004;40:879-89. (Pubitemid 39369559)
135. Dijkstra PU, Sterken MW, Pater R, Spijkervet FK, Roodenburg JL. Exercise therapy for trismus in head and neck cancer. Oral Oncol 2007;43:389-94. (Pubitemid 46413986)
136. Steelman R, Sokol J. Quantification of trismus following irradiation of the temporomandibular joint. Mo Dent J 1986;66:21-3.
137. Dijkstra PU, Huisman PM, Roodenburg JLN. Crtiteria for trismus in head and neck oncology. Int J Oral Maxillofac Surg 2006;35:337-42. (Pubitemid 43286265)
138. Wang CJ, Huang EY, Hsu HC, Chen HC, Fang FM, Hsiung CY. The degree and time-course assessment of radiation-induced trismus occurring after radiotherapy for nasopharyngeal cancer. Laryngoscope 2005;115:1458-60.
139. Ichimura K, Tanaka T. Trismus in patients with malignant tumors in the head and neck. J Laryngol Otol 1993;107:1017-20. (Pubitemid 23348536)
140. Gundlach KK. Ankylosis of the temporomandibular joint. J Craniomaxillofac Surg 2010;38:122-30.
141. Bhrany AD, Izzard M, Wood AJ, Futran ND. Coronoidectomy for the Treatment of Trismus in Head and Neck Cancer Patients. Laryngoscope 2007;117:1952-6. (Pubitemid 350059372)
142. Goldstein M, Maxymiw WG, Cummings BJ, Wood RE. The effects of antitumor irradiation on mandibular opening and mobility: A prospective study of 58 patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;88:365-73.
143. Steelman R, Sokol J. Quantification of trismus following irradiation of the temporomandibular joint. Mo Dent J 1986;66:21-3.
144. Buchbinder D, Currivan RB, Kaplan AJ, Urken ML. Mobilization regimens for the prevention of jaw hypomobility in the radiated patient: A comparison of three techniques. J Oral Maxillofac Surg 1993;51:863-7. (Pubitemid 23237077)
145. Cohen EG, Deschler DG, Walsh K, Hayden RE. Early use of a mechanical stretching device to improve mandibular mobility after composite resection: A pilot study. Arch Phys Med Rehabil 2005;86:1416-9. (Pubitemid 40909911)
146. Nitzan DW, Azaz B, Constantini S. Severe limitation in mouth opening following transtemporal neurosurgical procedures: Diagnosis, treatment, and prevention. J Neurosurg 1992;76:623-5.
147. Fujioka M, Daian T, Murakami R, Makino K. Release of extra-articular ankylosis by coronoidectomy and insertion of a free abdominal flap: Case report. J Craniomaxillofac Surg 2000;28:369-72. (Pubitemid 32243897)
148. Chua DT, Lo C, Yuen J, Foo YC. A Pilot Study of Pentoxifylline in the Treatment of Radiation-Induced Trismus. Am J Clin Oncol 2001;24:366-9. (Pubitemid 32730730)
149. Muhonen A, Peltomäki T, Hinkka S, Happonen RP. Effect of mandibular distraction osteogenesis on temporomandibular joint after previous irradiation and hyperbaric oxygenation. Int J Oral Maxillofac Surg 2002;31:397-404.
150. Marx RE. Osteoradionecrosis: A new concept of its pathophysiology. J Oral Maxillofac Surg 1983;41:283-8. (Pubitemid 13061964)
151. Marx RE. A new concept in the treatment of osteoradionecrosis. J Oral Maxillofac Surg 1983;41:351-7. (Pubitemid 13054600)
152. Regaud C. Sur la necrose des os attenté par un processus cancereux et traites par les radiaions. Compt Rend Soc Biol 1922;87:427.
153. Chrcanovic BR, Reher P, Sousa AA, Harris M. Osteoradionecrosis of the jaws-a current overview-part 1: Physiopathology and risk and predisposing factors. Oral Maxillofac Surg 2010;14:3-16.
154. Delanian S, Lefaix JL. The radiation-induced fibroatrophic process: Therapeutic perspective via the antioxidant pathway. Radiother Oncol 2004;73:119-31. (Pubitemid 39470150)
155. Dambrain R. The pathogenesis of osteoradionecrosis. Rev Stomatol Chir Maxillofac 1993;94:140-7.
156. Lyons A, Ghazali N. Osteoradionecrosis of the jaws: Current understanding of its pathophysiology and treatment. Br J Oral Maxillofac Surg 2008;46:653-60.
157. Niewald M, Barbie O, Schnabel K, Engel M, Schedler M, Nieder C, et al. Risk factors and dose-effect relationship for osteoradionecrosis after hyperfractionated and conventionally fractionated radiotherapy for oral cancer. Br J Radiol 1996;69:847-51. (Pubitemid 26325444)
158. Wahl MJ. Osteoradionecrosis Prevention Myths. Int J Radiat Oncol Biol Phys 2006;64:661-9. (Pubitemid 43183558)
159. Ben-David MA, Diamante M, Radawski JD, Vineberg KA, Stroup C, Murdoch-Kinch CA, et al. Lack of Osteoradionecrosis of the Mandible After Intensity -modulated Radiotherapy for Head and neck cancer: Likely Contribution of Both Dental Care and Improved Dose Distributions. Int J Radiat Oncol Biol Phys 2007;68:396-402. (Pubitemid 46694162)
160. Pasquier D, Hoelscher T, Schmutz J, Dische S, Mathieu D, Baumann M, et al. Hyperbaric oxygen therapy in the treatment of radioinduced lesions in normal tissues: a literature review. Radiother Oncol 2004;72:1-13. (Pubitemid 38952854)
161. Jereczek-Fossa BA, Orecchia R. Radiotherapy-induced mandibular bone complications. Cancer Treat Rev 2002;28:65-74. (Pubitemid 34679209)
162. Sulaiman F, Huryn JM, Zlotolow IM. Dental extractions in the irradiated head and neck patient: A retrospective analysis of Memorial Sloan-Kettering Cancer Center protocols, criteria, and end results. J Oral Maxillofac Surg 2003;61:1123-31. (Pubitemid 37193487)
163. Epstein JB, Rea G, Wong FL, Spinelli J, Stevenson-Moore P. Osteonecrosis: Study of the relationship of dental extractions in patients receiving radiotherapy. Head Neck Surg 1987;10:48-54. (Pubitemid 19098980)
164. Ardran G. Bone destruction not demonstrable by radiography. Br J Radiol 1951;24:107-9.